US 11878074
Methods of use of emulsion formulations of an NK-1 receptor antagonist
granted A61KA61K31/43A61K31/435
Quick answer
US patent 11878074 (Methods of use of emulsion formulations of an NK-1 receptor antagonist) held by Heron Therapeutics, Inc. expires Mon Jan 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Heron Therapeutics, Inc.
- Grant date
- Tue Jan 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K31/43, A61K31/435, A61K31/496, A61K31/5377